<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260609069722N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-06-20</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Effect of Diaphragm Manual Release Combined with Upper Trapezius Myofascial Release in Patients with Mechanical Neck Pain</public_title>
      <acronym></acronym>
      <scientific_title>Evaluating the Impact of Diaphragm Manual Release Combined with Upper Trapezius Myofascial Release on Mechanical Neck Pain and Active Trigger Points: A Randomized Controlled Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-06-17</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>28</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/90954</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: Two-arm parallel randomized controlled trial comparing upper trapezius myofascial release alone versus upper trapezius myofascial release combined with diaphragm manual release in patients with chronic mechanical neck pain. Treatment will be provided three times per week for four weeks, Randomization description: Eligible participants will be randomly allocated into two groups in a 1:1 ratio. Randomization will be performed using a computer-generated random sequence with allocation concealment through sequentially numbered opaque sealed envelopes prepared by an independent researcher, Blinding description: Outcome assessments will be performed by an independent physiotherapist who is blinded to group allocation. The assessor will not participate in treatment sessions and will remain unaware of the intervention received by participants.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Chronic Mechanical Neck Pain.</hc_freetext>
      <i_freetext>Intervention 1: Control group: Participants will receive upper trapezius myofascial release only, three sessions per week for four weeks. Each session will last approximately 15 minutes. Intervention 2: Intervention group: Participants will receive upper trapezius myofascial release combined with diaphragm manual release, three sessions per week for four weeks. Each session will last approximately 25 minutes.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
De-identified participant dataset, study protocol, statistical analysis results, and informed consent template related to the trial evaluating diaphragm manual release combined with upper trapezius myofascial release in patients with chronic mechanical neck pain.

When:
Data and supporting documents will be available upon reasonable request beginning 6 months after publication of the study results and will remain available for 5 years.

To whom:
De-identified data and study documents will be available to qualified researchers, clinicians, and academic investigators conducting scientific research.

Conditions:
Data may be used for scientific research, secondary analyses, systematic reviews, and meta-analyses following approval of a reasonable research proposal.

Where to obtain:
Requests should be sent by email to the principal investigator, Mohammed Basim Mohammed Alkhafajy, at the corresponding study email address.

How to obtain:
Researchers must submit a written request describing the purpose of data use. Requests will be reviewed by the principal investigator, and approved applicants will receive access to de-identified data.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammed Basim Mohammed Alkhafajy</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>House 53, Alley 68, District 334, Al-Kurayat, Baghdad, Iraq</address>
        <city>Baghdad</city>
        <country1>Iraq</country1>
        <zip>00000</zip>
        <telephone>+964 770 298 4898</telephone>
        <email>mbmhkh1989@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Azadeh Shadmehr</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>International Campus, Tehran University of Medical Sciences, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>00000</zip>
        <telephone>+98 912 370 3379</telephone>
        <email>shadmehr@tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iraq</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age 18–55 years.
Mechanical neck pain for more than 3 months
NPRS between 30–80 mm
At least one active upper trapezius trigger point
BMI 18.5–29.9.
Ability to attend treatment sessions
Ability to understand questionnaires.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>55 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Cervical trauma or surgery
Neurological disorders
Respiratory disorders
Radicular pain
Pregnancy
Recent neck pain intervention
Inability to complete assessments</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M54.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Cervicalgia</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: Participants will receive upper trapezius myofascial release only, three sessions per week for four weeks. Each session will last approximately 15 minutes.</i_keyword>
      <i_keyword>Intervention group: Participants will receive upper trapezius myofascial release combined with diaphragm manual release, three sessions per week for four weeks. Each session will last approximately 25 minutes.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain Intensity. Timepoint: Before intervention and immediately after completion of the 4-week treatment program. Method of measurement: Numeric Pain Rating Scale (NPRS), 0–10 scale.</prim_outcome>
      <prim_outcome>Neck Disability. Timepoint: Before intervention and immediately after completion of the 4-week treatment program. Method of measurement: Neck Disability Index (NDI).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Pain Pressure Threshold (PPT). Timepoint: Before intervention and immediately after completion of the 4-week treatment program. Method of measurement: Measured using a digital pressure algometer over the upper trapezius trigger point (kg/cm²).</sec_outcome>
      <sec_outcome>Cervical Range of Motion (ROM). Timepoint: Before intervention and immediately after completion of the 4-week treatment program. Method of measurement: Measured using an inclinometer for cervical flexion, extension, lateral flexion, and rotation (degrees).</sec_outcome>
      <sec_outcome>Chest Expansion. Timepoint: Before intervention and immediately after completion of the 4-week treatment program. Method of measurement: Measured using a tape measure at the xiphoid level during maximum inspiration and expiration (cm).</sec_outcome>
      <sec_outcome>Patient Global Impression of Change (PGIC). Timepoint: Immediately after completion of the 4-week treatment program. Method of measurement: Measured using the 7-point Patient Global Impression of Change (PGIC) scale.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-01-05</approval_date>
        <contact_name>Ethics Committee of Faculty of Nursing and Midwifery and Rehabilitation, Tehran University of Medica</contact_name>
        <contact_address>Tehran, Shahrak Qods (West), between South Flamack and Zarafshan, Simaye Iran Street - Central Headquarters of the Ministry of Health, Treatment and Medical Education, Block A, 13th Floor Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
